28.06.2019 • News

Advanced and SK Plan Saudi Complexes

Advanced and SK Plan Saudi Complexes (c) Advanced Global Investment Company
Advanced and SK Plan Saudi Complexes (c) Advanced Global Investment Company

Advanced Global Investment Company (AGIC), a subsidiary of PP producer Advanced Petrochemical, has signed three separate Memoranda of Understanding (MoUs) with SK Gas, an affiliate of South Korea’s SK Group, to build petrochemicals and propane dehydrogenation (PDH)/PP complexes in Jubail Industrial City, Saudi Arabia.

The first agreement covers the construction of a mixed feed or liquid cracker and downstream products. Under the terms of the MoU, the companies will carry out a detailed feasibility study including a technical evaluation of new and conventional technologies, a detailed market study of potential products, an assessment of the project costs and development of a financial model.

The partners did not disclose the size of the cracker.

A second MoU covers the development of a PDH/PP complex. This project, which has an estimated cost of $1.8 billion, will produce 750,000 t/y of both propylene and PP. Start-up is scheduled by the second half of 2024.

The PP plant will produce value-added grades to manufacture compounds for the automotive industry as well as other specialized grades that the Kingdom currently imports. A 100,000 t/y PP compounding plant will be built under the third MoU at a cost of $40 million.

A portion of the propylene output from the PDH unit will also feed a 70,000 t/y isopropanol plant. Investment costs for this plant are expected to be $100 million.

Advanced said it has received an allocation of propane feedstock for the PDH plant from the Ministry of Energy, Industry and Mineral Resources.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read